Erythrocyte sedimentation rate and C-reactive protein. 1976

M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer

C-reactive protein (CRP) was isolated from pleura exudate of patients with metastasing cancer and added to plasma of healthy blood donors. Only the addition of excessive amounts of CRP (220 mg/ml) caused a notable increase in erythrocyte sedimentation rate. An immunoelectrophoretic method for the simultaneous quantitative determination of CRP together with C 3 or other acute phase reactants is described.

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D008297 Male Males
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D001799 Blood Sedimentation Measurement of rate of settling of ERYTHROCYTES in blood. Erythrocyte Sedimentation,Erythrocyte Sedimentation Rate,Erythrocyte Sedimentation Rates,Rate, Erythrocyte Sedimentation,Rates, Erythrocyte Sedimentation,Sedimentation Rate, Erythrocyte,Sedimentation Rates, Erythrocyte,Sedimentation, Blood,Sedimentation, Erythrocyte
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D005260 Female Females

Related Publications

M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
June 2015, Australian prescriber,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
November 1956, Bulletin on the rheumatic diseases,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
February 2010, PloS one,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
January 2020, American journal of clinical pathology,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
August 2009, The Journal of rheumatology,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
March 1989, Clinical chemistry,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
January 2007, Clinical and experimental rheumatology,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
January 1997, British journal of hospital medicine,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
June 2013, Zeitschrift fur Rheumatologie,
M Abd-El-Fattah, and R Scherer, and G Ruhenstroth-Bauer
May 1978, British medical journal,
Copied contents to your clipboard!